iOnctura’s roginolisib awarded Innovation Passport
MHRA designation involves entry into innovative licensing and access pathway
Read More
Tag: innovation passport
Innovation Passport awarded Alnylam and its hypertension therapy
The company received the Innovation Passport in the UK for zilebesiran, an investigational treatment of hypertension
Read More
bluebird bio’s sickle cell gene therapy granted MHRA ‘innovation passport’
Innovation passport designation scheme aims to reduce the time to market for promising treatments
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
